A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Clinical trial NCT00335205 · UNKNOWN

Trial details

NCT number: NCT00335205
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder Major Depressive Disorder

Start date: 2003-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.